The present invention provides a novel therapeutical agent for treating myelofibrosis.A carrier for delivering substance, which comprises a retinoid and delivers the substance to extracellular matrix-generation cell in the bone marrow, as well as a therapeutical agent is used to treat myelofibrosis by using the medicaments which control the activity and proliferation of extracellular matrix-generation cell in the bone marrow.